Lauxera Capital Partners raises a hefty €520M for health, medtech companies Read more →
Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial Read more →
Relay ‘full steam ahead’ on PI3K inhibitor fueled by first phase 2 data in blood vessel disorder Read more →
